Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients seeking treatment for osteoarthritis and there are clinical or radiological evidence of the disease,~* Male or female, age ≥ 18~* Designated to treatment with Ibuprofen in a sustained release form (Brufen Retard) according to the best criterion of the physician and if he decides to treat the patient according to labeled indication and dose for 4 weeks.~* Patients who have given their written informed consent to participate in the study~* Patients who are currently taking non steroidal anti inflammatory drugs (NSAIDs), should complete an initial washout phase 10 days depending on the half life of the drug taken~Exclusion Criteria:~* Contraindications as described in company core data sheet (CCDS) and specifically~* Patients with active peptic ulcer~* Patients who have presented reactions of hypersensitivity (asthma , rhinitis or urticaria ) with ibuprofen or other anti-inflammatory non steroids~* Patients with active cardiovascular disease and those taking aspirin/warfarin for prophylaxis for myocardial infarction (MI) or stroke~* Patients with moderate to severe renal diseases~* Patients with moderate to severe hepatic disease~* Patients with Crohn's disease~* Patients included currently in another study~* Women of childbearing potential must not be pregnant~* Any patients the investigators consider ineligible for this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Osteoarthritic patients (Type: None): Patients male or female, age ≥ 18 having clinical or radiological evidence of osteoarthritis

Based on this trial design, predict the completion outcome and termination type (if applicable).